Skip to main content

Advertisement

SpringerLink
Log in

The impact of inherited thrombophilia on surgery: A factor to consider before transplantation?

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

This article mainly reviews hypercoagulability—and specifically inherited thrombophilia—in different types of surgery including kidney transplantation, simultaneous kidney and pancreas transplantation, orthopedic surgery, vascular surgery, cardiac surgery and other categories of surgical procedures, with a major focus on its associated complications and the need to screen or not. A search was conducted using Medline and cross-referencing for articles related to thrombophilia, screening for it, and its association with surgical complications post-op. Thrombosis associated predisposing entities like factor V Leiden, Prothrombin and Methylene tetrahydrofolate reductase gene mutations, in addition to Protein C and S deficiencies, are discussed. In addition, common and relatively uncommon complications of thrombophilia in the above mentioned surgeries will be covered in length, as well as the necessity to screen for thrombophilia prior to the surgical step. This topic is gaining more and more importance for both surgeons and internists (especially Hematologists) and we, herein, present a general review of the published literature as an update on the subject.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Goldhaber SZ (1994) Epidemiology of pulmonary embolism and deep vein thrombosis. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EG (eds) Haemostasis and thrombosis. Churchill Livingstone, New York, p 1327

    Google Scholar 

  2. Nordström M, Lindblad B, Bergqvist D, Kjellström T (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232:155–160

    PubMed  Google Scholar 

  3. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B et al (1991) A population based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med 151:933–938. doi:10.1001/archinte.151.5.933

    PubMed  Google Scholar 

  4. Walker ID, Greaves M (2001) On behalf of the haemostasis and thrombosis task force British committee for standards in haematology. Investigation and management of heritable thrombophilia. Br J Haematol 114:512–528. doi:10.1046/j.1365-2141.2001.02981.x

    CAS  Google Scholar 

  5. Weitz J, Middeldorp S, Geerts W, Heit JA (2004) Thrombophilia and new anticoagulant drugs. Hematology 20:424–438. doi:10.1182/asheducation-2004.1.424

    Google Scholar 

  6. Thomas RH (2001) Hypercoagulability syndromes. Arch Intern Med 161:2433–2439. doi:10.1001/archinte.161.20.2433

    PubMed  CAS  Google Scholar 

  7. Voorberg J, Roelse J, Koopman R, Büller H, Berends F, ten Cate JW et al (1994) Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet 343:1535. doi:10.1016/S0140-6736(94)92939-4

    PubMed  CAS  Google Scholar 

  8. Zoller B, Holm J, Svensson P, Dahlbäck B (1996) Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency. Thromb Haemost 75:270

    PubMed  CAS  Google Scholar 

  9. Margaglione M, Brancaccio V, Giuliani N, D’Andrea G, Cappucci G, Iannaccone L et al (1998) Increased risk for venous thrombosis in carriers of prothrombin G A20210 gene variant. Ann Intern Med 129:89–93

    PubMed  CAS  Google Scholar 

  10. Dahlback B (2005) Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med 257:209–223. doi:10.1111/j.1365-2796.2004.01444.x

    PubMed  Google Scholar 

  11. Olsson E, Hoijer P (2005) Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases. Br J Plast Surg 58:720–723. doi:10.1016/j.bjps.2004.12.024

    PubMed  Google Scholar 

  12. DeStefano U, Chiusolo P, Paciaroni K, Leone G (1998) Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 24:367–379

    CAS  Google Scholar 

  13. Svensson PJ, Zoller B, Mattiasson I, Dahlbäck B (1997) The factor V R506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis. J Intern Med 241:379–385. doi:10.1046/j.1365-2796.1997.124140000.x

    PubMed  CAS  Google Scholar 

  14. Rees DC, Cox M, Clegg JB (1995) World distribution of factor V Leiden. Lancet 346:1133–1134. doi:10.1016/S0140-6736(95)91803-5

    PubMed  CAS  Google Scholar 

  15. Isma’eel H, El Accaoui R, Shamseddeen W, Taher A, Alam S, Mahfouz R et al (2006) Genetic thrombophilia in patients with VTE in eastern mediterranean located tertiary care center; is it time to change the algorithm for thrombophilia work up decision making? J Thromb Thrombolysis 21:267–270. doi:10.1007/s11239-006-5537-1

    PubMed  CAS  Google Scholar 

  16. Tait RC, Walker ID, Reitsma PH, Islam SI, McCall F, Poort SR et al (1995) Prevalence of protein C deficiency in the healthy population. Thromb Haemost 73:87–93

    PubMed  CAS  Google Scholar 

  17. Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F et al (1998) Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 92:2353–2358

    PubMed  CAS  Google Scholar 

  18. Seligsohn U, Berger A (1984) Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 310:559

    PubMed  CAS  Google Scholar 

  19. Bick R (2003) Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects. Hematol Oncol Clin North Am 17:9–36. doi:10.1016/S0889-8588(02)00101-6

    PubMed  Google Scholar 

  20. Sanson BJ, Simioni P, Tormene D, Moia M, Friederich PW, Huisman MV et al (1999) On behalf of the TACT-study group. The incidence of venous thromboembolism in asymptomatic carriers of a marker of thrombophilia. Blood 94:3702–3706

    PubMed  CAS  Google Scholar 

  21. Gladson KH, Scharrer I, Hach V, Beck KH, Griffin JH (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59:18–22

    PubMed  CAS  Google Scholar 

  22. Brown K, Luddington R, Williamson D, Baker P, Baglin T (1997) Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3’-untranslated region of the prothrombin gene. Br J Haematol 98:907–909. doi:10.1046/j.1365-2141.1997.3093130.x

    PubMed  CAS  Google Scholar 

  23. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variant in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in thrombosis. Blood 88:3698–3703

    PubMed  CAS  Google Scholar 

  24. Tait RC, Walker ID, Perry DJ, Islam SI, Daly ME, McCall F et al (1994) Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 87:106–112. doi:10.1111/j.1365-2141.1994.tb04878.x

    PubMed  CAS  Google Scholar 

  25. Odegard O, Abildgaard U (1978) Antithrombin-III: critical review of assay methods. Significance of variations in health and disease. Haemostasis 7:127 (Abstract)

    PubMed  CAS  Google Scholar 

  26. Rosenberg RD (1975) Action and interaction of antithrombin and heparin. N Engl J Med 292:146

    PubMed  CAS  Google Scholar 

  27. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113. doi:10.1038/ng0595-111

    PubMed  CAS  Google Scholar 

  28. Kirke PN, Mills JL, Whitehead AS, Molloy A, Scott JM (1996) Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 348:1037–1038. doi:10.1016/S0140-6736(05)64971-9

    PubMed  CAS  Google Scholar 

  29. de Franchis R, Sebastio G, Mandato C, Andria G, Mastroiacovo P (1995) Spina bifida, 677TC mutation and role of folate. Lancet 346:1703. doi:10.1016/S0140-6736(95)92865-0

    PubMed  Google Scholar 

  30. Arruda VR, Von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF (1997) The mutation Ala677→Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 77:818–821

    PubMed  CAS  Google Scholar 

  31. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG, MTHFR Studies Collaboration Group (2002) MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288:2023–2031. doi:10.1001/jama.288.16.2023

    PubMed  CAS  Google Scholar 

  32. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR (2007) No association between the common MTHFR 677C-T polymorphism and venous thrombosis. Results from the MEGA study. Arch Intern Med 167:497–501. doi:10.1001/archinte.167.5.497

    PubMed  CAS  Google Scholar 

  33. Den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM (1998) Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80:874–877

    Google Scholar 

  34. Petri M (2000) Epidemiology of the antiphospholipid syndrome. J Autoimmun 15:145–151. doi:10.1006/jaut.2000.0409

    PubMed  CAS  Google Scholar 

  35. Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in SLE and in non-SLE disorders. Ann Intern Med 112:682–698

    PubMed  CAS  Google Scholar 

  36. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT et al, Euro-Phospholipid Project Group (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019–1027. doi:10.1002/art.10187

    PubMed  Google Scholar 

  37. Rand J (2003) The antiphospholipid syndrome. Annu Rev Med 54:409–424. doi:10.1146/annurev.med.54.101601.152412

    PubMed  CAS  Google Scholar 

  38. Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, Eikenboom JC, Bertina RM, Rosendaal FR (1998) Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost 79:323–327

    PubMed  CAS  Google Scholar 

  39. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–155. doi:10.1016/S0140-6736(95)90166-3

    PubMed  CAS  Google Scholar 

  40. Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS (2005) Kidney and pancreas transplantation in the United States, 1996–2005. Am J Transplant 7:1359–1375. doi:10.1111/j.1600-6143.2006.01781.x

    Google Scholar 

  41. Green FR (2000) Genetic predisposition to thrombosis in renal transplant recipients: the factor V Q506 (Leiden) allele. Transplantation 69:1547–1548. doi:10.1097/00007890-200004270-00004

    PubMed  CAS  Google Scholar 

  42. John U, Kentouche K, Nowak G, Schubert J, Misselwitz J (2006) Successful renal transplantation in a patient with heterozygous prothrombin gene, factor V Leiden mutation and heparin induced thrombocytopenia using r-hirudin. Pediatr Transplant 10:114–118. doi:10.1111/j.1399-3046.2005.00398.x

    PubMed  CAS  Google Scholar 

  43. Singh A, Stablein D, Tejani A (1997) Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 63:1263. doi:10.1097/00007890-199705150-00012

    PubMed  CAS  Google Scholar 

  44. Matas AJ, Humar A, Payne WD, Gillingham KJ, Dunn DL, Sutherland DE et al (1999) Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. Ann Surg 230:493. doi:10.1097/00000658-199910000-00005

    PubMed  CAS  Google Scholar 

  45. Vanrenterghem Y (1999) Vascular rejection with tacrolimus and potential long-term graft outcome. Transplant Proc 31:86S–87S. doi:10.1016/S0041-1345(99)00805-2

    PubMed  CAS  Google Scholar 

  46. Hocher B, Slowinski T, Hauser I, Vetter B, Fritsche L, Bachert D et al (2002) Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients. Thromb Haemost 87:194–198

    PubMed  CAS  Google Scholar 

  47. Irish AB, Green FR (1997) Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 12:167. doi:10.1093/ndt/12.1.167

    PubMed  CAS  Google Scholar 

  48. Ekberg H, Svensson PJ, Simanaitis M, Dahlbäck B (2000) Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection. Transplantation 69:1577–1581. doi:10.1097/00007890-200004270-00010

    PubMed  CAS  Google Scholar 

  49. Fischereder M, Gohring P, Schneeberger H, Lohse P, Von Appen K, Samtleben W et al (1998) Early loss of renal transplants in patients with thrombophilia. Transplantation 65:936–939. doi:10.1097/00007890-199804150-00013

    PubMed  CAS  Google Scholar 

  50. Oh J, Schaefer F, Veldmann A, Nowak G, Nowak-Göttl U, Tönshoff B et al (1999) Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis. Transplantation 68:575–578. doi:10.1097/00007890-199908270-00022

    PubMed  CAS  Google Scholar 

  51. Heidenreich S, Dercken C, August C, Koch HG, Nowak-Göttl U (1998) High rate of acute rejections in renal allograft recipients with thrombophilic risk factors. J Am Soc Nephrol 9:1309

    PubMed  CAS  Google Scholar 

  52. Ekmekci Y, Keven K, Akar N, Egin Y, Sengul S, Kutlay S et al (2006) Thrombophilia and avascular necrosis of femoral head in kidney allograft recipients. Nephrol Dial Transplant 21:3555–3558. doi:10.1093/ndt/gfl400

    PubMed  CAS  Google Scholar 

  53. Fischereder M, Schneeberger H, Lohse P, Krämer BK, Schlöndorff D, Land W (2001) Increased rate of renal transplant failure in patients with the G20210A mutation of the prothrombin gene. Am J Kidney Dis 38:1061–1064. doi:10.1053/ajkd.2001.28602

    PubMed  CAS  Google Scholar 

  54. Forman JP, Lin J, Pascual M, Denton MD, Tolkoff-Rubin N (2004) Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant 4:1786–1791. doi:10.1046/j.1600-6143.2004.00602.x

    PubMed  CAS  Google Scholar 

  55. Arruda VR, Belangero WD, Ozelo MC, Oliveira GB, Pagnano RG, Volpon JB et al (1999) Inherited risk factor for thrombophilia among children with Legg-Calve-Perthes disease. J Pediatr Orthop 19:84–87. doi:10.1097/00004694-199901000-00019

    PubMed  CAS  Google Scholar 

  56. Alkhunaizi AM, Olyaei AJ, Barry JM, deMattos AM, Conlin MJ, Lemmers MJ et al (1998) Efficacy and safety of low molecular weight heparin in renal transplantation. Transplantation 66:533–534. doi:10.1097/00007890-199808270-00020

    PubMed  CAS  Google Scholar 

  57. Robertson AJ, Nargund V, Gray DW, Morris PJ (2000) Lowdose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients. Nephrol Dial Transplant 15:1865–1868. doi:10.1093/ndt/15.11.1865

    PubMed  CAS  Google Scholar 

  58. Murphy GJ, Taha R, Windmill DC, Metcalfe M, Nicholson ML (2001) Influence of aspirin on early allograft thrombosis and chronic nephropathy following renal transplantation. Br J Surg 88:261–266. doi:10.1046/j.1365-2168.2001.01671.x

    PubMed  CAS  Google Scholar 

  59. Kandaswamy R, Humar A, Gruessner AC, Harmon JV, Granger DK, Lynch S et al (1999) Vascular graft thrombosis after pancreas transplantation: comparison of the FK 506 and cyclosporine eras. Transplant Proc 31:602. doi:10.1016/S0041-1345(98)01574-7

    PubMed  CAS  Google Scholar 

  60. Bynon JS, Stratta RJ, Taylor RJ, Lowell JA, Cattral M (1993) Vascular reconstruction in 105 consecutive pancreas transplants. Transplant Proc 25:3288

    PubMed  CAS  Google Scholar 

  61. Sollinger HW, Odorico JS, Knechtle SJ, D’Alessandro AM, Kalayoglu M, Pirsch JD (1998) Experience with 500 simultaneous pancreas–kidney transplants. Ann Surg 228:284. doi:10.1097/00000658-199809000-00002

    PubMed  CAS  Google Scholar 

  62. Leggington R, Olivero JJ, Adrogue HE, Ramanathan V (2005) Recovery of allograft function after complete withdrawal of immunosuppression. Transplant Proc 370:4380–4382. doi:10.1016/j.transproceed.2005.10.027

    Google Scholar 

  63. Burke GW III, Ciancio G, Figueiro J, Buigas R, Olson L, Roth D et al (2004) Hypercoagulable state associated with kidney–pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy. Clin Transplant 18:423–428. doi:10.1111/j.1399-0012.2004.00183.x

    PubMed  Google Scholar 

  64. Adrogué HE, Matas AJ, McGlennon RC, Key NS, Gruessner A, Gruessner RW et al (2007) Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients? Clin Transplant 21:32–37. doi:10.1111/j.1399-0012.2006.00574.x

    PubMed  Google Scholar 

  65. Andrassy J, Zeier M (2004) Do we need screening for thrombophilia prior to kidney transplantation? Nephrol Dial Transplant 19:64–68. doi:10.1093/ndt/gfh1045

    Google Scholar 

  66. Turpie AGG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ et al (1986) A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 315:925–929

    PubMed  CAS  Google Scholar 

  67. Bergqvist D (1992) Review of clinical trials of low molecular weight heparins. Clinical review. Eur J Surg 158:67–68

    PubMed  CAS  Google Scholar 

  68. Collins R, Scrimgeour A, Yusuf S, Peto R (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 318:1162–1173

    PubMed  CAS  Google Scholar 

  69. Bergqvist B, Benoni G, Björgell O, Fredin H, Hedlundh U, Nicolas S et al (1996) Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 335:696–700. doi:10.1056/NEJM199609053351002

    PubMed  CAS  Google Scholar 

  70. Dahl OE, Andreassen G, Aspelin T, Müller C, Mathiesen P, Nyhus S et al (1997) Prolonged thromboprophylaxis following hip replacement surgery—results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin®). Thromb Haemost 77:26–31

    PubMed  CAS  Google Scholar 

  71. Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y (1996) Risk of deep venous thrombosis after hospital discharge in patients undergoing total hip replacement. Double-blind randomised comparison of enoxaparin versus placebo. Lancet 348:224–228. doi:10.1016/S0140-6736(96)01453-5

    PubMed  CAS  Google Scholar 

  72. Wåhlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D et al (2002) Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost 87:580–585

    PubMed  Google Scholar 

  73. Campos M, Morais S (2000) Absence of venous thromboembolism during orthopedic surgery in patients with FV Leiden mutation or 20210A allele of prothrombin gene. Haemostasis 30:35. doi:10.1159/000054155

    Google Scholar 

  74. Ryan DH, Crowther MA, Ginsberg JS, Francis CW (1998) Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ann Intern Med 128:270–276

    PubMed  CAS  Google Scholar 

  75. Svensson PJ, Benoni G, Fredin H, Björgell O, Nilsson P, Hedlund U et al (1997) Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty. Thromb Haemost 78:993–996

    PubMed  CAS  Google Scholar 

  76. Lindahl TL, Lundahl TH, Nilsson L, Andersson CA (1999) APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee-a prospective study. Thromb Haemost 81:18–21

    PubMed  CAS  Google Scholar 

  77. Salvati EA, Della Valle AG, Westrich GH, Rana AJ, Specht L, Weksler BB et al (2005) The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res 441:40–55. doi:10.1097/01.blo.0000192366.61616.81

    PubMed  Google Scholar 

  78. Donahue BS (2004) Factor V Leiden and perioperative risk. Anesth Analg 98:1623–1634. doi:10.1213/01.ANE.0000113545.03192.FD

    PubMed  CAS  Google Scholar 

  79. Ray SA, Rowley MR, Loh A, Talbot SA, Bevan DH, Taylor RS et al (1994) Hypercoagulable states in patients with leg ischaemia. BJS 81:811–814. doi:10.1002/bjs.1800810607

    CAS  Google Scholar 

  80. Svensson PJ, Dahlbick B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517–522. doi:10.1056/NEJM199402243300801

    PubMed  CAS  Google Scholar 

  81. Donaldson MC, Weinberg DS, Belkin M, Whittemore AD, Mannick JA (1990) Screening for hypercoagulable states in vascular surgical practice. J Vasc Surg 11:825–831. doi:10.1067/mva.1990.20120

    PubMed  CAS  Google Scholar 

  82. Vig S, Chitolie A, Sleight S, Bevan D, Dormandy J, Thompson MM et al (2004) Prevalence and risk of thrombophilia defects in vascular patients. Eur J Vasc Endovasc Surg 28:124–131

    PubMed  CAS  Google Scholar 

  83. Taylor LM Jr, Chitwood RW, Dalman RL, Sexton G, Goodnight SH, Porter JM (1994) Antiphospholipid antibodies in vascular surgery patients: a cross-sectional study. Ann Surg 220:544–551. doi:10.1097/00000658-199410000-00012

    PubMed  Google Scholar 

  84. Lee RW, Taylor LM, Landry GJ, Goodnight SH, Moneta GL, Edwards JM et al (1996) Prospective comparison of infrainguinal bypass grafting in patients with and without Antiphospholipid antibodies. J Vasc Surg 24:524–533. doi:10.1016/S0741-5214(96)70068-X

    PubMed  CAS  Google Scholar 

  85. Eldrup-Jorgensen J, Flanigan D, Flanigan DP, Brace L, Sawchuk AP, Mulder SG et al (1989) Hypercoagulable states and lower limb ischaemia in young adults. J Vasc Surg 9:334–341. doi:10.1067/mva.1989.vs0090334

    PubMed  CAS  Google Scholar 

  86. Ahn SS, Kalunian K, Rosove M, Moore WS (1988) Postoperative thrombotic complications in patients with the lupus anticoagulant: increased risk after vascular procedures. J Vasc Surg 7:749–756. doi:10.1067/mva.1988.avs0070749

    PubMed  CAS  Google Scholar 

  87. Shortell CK, Ouriel K, Green RM, Condemi JJ, DeWeese JA (1992) Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis. J Vasc Surg 15:158–166. doi:10.1067/mva.1992.33164

    PubMed  CAS  Google Scholar 

  88. Nitecki S, Brenner B, Hoffman A, Lanir N, Schramek A, Torem S (1993) Lower limb ischaemia in primary antiphospholipid syndrome. Eur J Vasc Endovasc Surg 7:414–419

    CAS  Google Scholar 

  89. Collins G, Heymann RL, Zajtchuk R (1975) Hypercoagulability in patients with peripheral vascular disease. Am J Surg 130:2–6. doi:10.1016/0002-9610(75)90444-4

    PubMed  Google Scholar 

  90. Flinn WR, McDaniel MD, Yao JS, Fahey VA, Green D (1984) Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstruction. J Vasc Surg 1:888–895. doi:10.1067/mva.1984.avs0010888

    PubMed  CAS  Google Scholar 

  91. Ouriel K, Green RM, DeWeese JA, Cimino C (1996) Activated protein C resistance: prevalence and implications in peripheral vascular disease. J Vasc Surg 23:46–57. doi:10.1016/S0741-5214(05)80034-5

    PubMed  CAS  Google Scholar 

  92. Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y (2004) Increased morbidity and mortality in patients with antiphopholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg 127:414–420. doi:10.1016/j.jtcvs.2003.07.016

    PubMed  Google Scholar 

  93. Massoudy P, Cetin SM, Thielmann M, Kienbaum P, Piotrowski JA, Marggraf G et al (2005) Antiphospholipid syndrome in cardiac surgery—an underestimated coagulation disorder? Eur J Cardiothorac Surg 28:133–137. doi:10.1016/j.ejcts.2004.12.062

    PubMed  Google Scholar 

  94. De Paulis R, Bognolo G, Tomai F, Bassano C, Tracey M, Chiariello L (1996) Early coronary artery bypass graft thrombosis in a patient with protein S deficiency. Eur J Cardiothorac Surg 10:470–472. doi:10.1016/S1010-7940(96)80119-9

    PubMed  Google Scholar 

  95. Schneider S, Sakert T, Lucke J, McKeown P, Sharma A (2006) Cardiopulmonary bypass for a coronary artery bypass graft patient with heterozygous protein C deficiency and protein S deficiency. Perfusion 21:117–120. doi:10.1191/0267659106pf853oa

    PubMed  Google Scholar 

  96. Arboix A, Bechich S, Oliveres M, García-Eroles L, Massons J, Targa C (2001) Ischemic stroke of unusual cause: clinical features, etiology, and outcome. Eur J Neurol 8:133–139. doi:10.1046/j.1468-1331.2001.00180.x

    PubMed  CAS  Google Scholar 

  97. Ninomiya M, Makuuchi H, Ohtsuka T, Takamoto S (2001) Ischemic heart disease associated with protein C deficiency. Eur J Cardiothorac Surg 20:883–885. doi:10.1016/S1010-7940(01)00914-9

    PubMed  CAS  Google Scholar 

  98. Oysel N, Bonnet J, Vergnes C, Benchimol D, Boisseau MR, Moreau C, Bernadet P, Baudet E, Larrue J, Bricaud H (1989) Risk factors for myocardial infarction during coronary artery bypass graft surgery. Eur Heart J 10:806–815

    PubMed  CAS  Google Scholar 

  99. So GM, Herbert MR, Dooling EC, Buonanno F, Kosofsky BE, Ebb D (1998) Multifocal embolic strokes following cardiac surgery in a protein C-deficient child. J Child Neurol 13:629–631

    Article  PubMed  CAS  Google Scholar 

  100. Morozowich ST, Donahue BS, Welsby IJ (2006) Genetics of coagulation: considerations for cardiac surgery. Semin Cardiothorac Vasc Anesth 10:297–313. doi:10.1177/1089253206294345

    PubMed  Google Scholar 

  101. Loubser PG, McCarthy JJ, Attar M (1997) Coronary thrombosis associated with antithrombin-III deficiency. J Cardiothorac Vasc Anesth 11:756–759. doi:10.1016/S1053-0770(97)90171-3

    PubMed  CAS  Google Scholar 

  102. Despotis GJ, Gravlee G, Filos K, Levy J (1999) Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 91:1122–1151. doi:10.1097/00000542-199910000-00031

    PubMed  CAS  Google Scholar 

  103. Avidan MS, Levy JH, van Aken H, Feneck RO, Latimer RD, Ott E et al (2005) Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. J Thorac Cardiovasc Surg 130:107–113. doi:10.1016/j.jtcvs.2004.10.045

    PubMed  CAS  Google Scholar 

  104. Sweeney JD, Blair AJ, Dupuis MP, King TC, Moulton AL (1997) Aprotinin, cardiac surgery, and factor V Leiden. Transfusion 37:1173–1178. doi:10.1046/j.1537-2995.1997.37111298088048.x

    PubMed  CAS  Google Scholar 

  105. Moor E, Silveira A, van’t Hooft F, Tornvall P, Blombäck M, Wiman B et al (1998) Coagulation factor V (Arg506→Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Thromb Haemost 80:220–224

    PubMed  CAS  Google Scholar 

  106. Welsby IJ, Podgoreanu MV, Phillips-Bute B, Mathew JP, Smith PK, Newman MF et al, Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team (2005) Genetic factors contribute to bleeding after cardiac surgery. J Thromb Haemost 3:1206–1212. doi:10.1111/j.1538-7836.2005.01337.x

    PubMed  CAS  Google Scholar 

  107. Ravin AJ, Edwards RP, Krohn A, Kelley M Jr, Christopherson WA, Roberts JM (2002) The factor V Leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients. Obstet Gynecol 100:1285–1289. doi:10.1016/S0029-7844(02)02320-7

    PubMed  CAS  Google Scholar 

  108. Arnljots B, Soderstrom T, Svensson H (1998) No correlation between activated protein C resistance and free flap failures in 100 consecutive patients. Plast Reconstr Surg 101:1850–1853. doi:10.1097/00006534-199806000-00011

    PubMed  CAS  Google Scholar 

  109. Schusterman MA, Miller MJ, Reece GP, Kroll SS, Marchi M, Goepfert H (1994) A single center’s experience with 308 free flaps for repair of head and neck cancer defects. Plast Reconstr Surg 93:472–478

    PubMed  CAS  Google Scholar 

  110. Hidalgo DA, Jones CS (1990) The role of emergent exploration in free-tissue transfer: a review of 150 consecutive cases. Plast Reconstr Surg 86:492–498

    Article  PubMed  CAS  Google Scholar 

  111. Ayala C, Blackwell KE (1999) Protein C deficiency in microvascular head and neck reconstruction. Laryngoscope 109:259–265. doi:10.1097/00005537-199902000-00016

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, American University of Beirut Medical School, Beirut, Lebanon

    Elias Kfoury & Said Saghieh

  2. Department of Internal Medicine, American University of Beirut Medical School, Beirut, Lebanon

    Ali Taher

  3. Department of Pathology & Laboratory Medicine, American University of Beirut Medical Center (AUBMC), P.O. Box 11-0236, Riad El Solh, 1107 2020, Beirut, Lebanon

    Zaher K. Otrock & Rami Mahfouz

Authors
  1. Elias Kfoury
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Taher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Said Saghieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zaher K. Otrock
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rami Mahfouz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rami Mahfouz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kfoury, E., Taher, A., Saghieh, S. et al. The impact of inherited thrombophilia on surgery: A factor to consider before transplantation?. Mol Biol Rep 36, 1041–1051 (2009). https://doi.org/10.1007/s11033-008-9278-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-008-9278-4

Keywords

Search

Navigation